Sensorium Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Sensorium Therapeutics is a Boston-based biotechnology company focused on developing brain and mental health treatments derived from nature, with a mechanistic and clinically precise approach aimed at helping people thrive. Its proprietary SensAI platform blends artificial intelligence with chemistry and neuroscience to identify starting points for central nervous system drug discovery, leveraging a large set of curated biological and clinical relationships to inform program development. The company has advanced multiple programs, led by SENS-01, a first-in-class candidate targeting anxiety, and operates within the biotechnology research sector that seeks psychoactive medicines for neuropsychiatric diseases. Sensorium’s team and leadership have evolved with new appointments, including a recent transition in executive leadership and board composition to support its clinical-stage pipeline. The organization is headquartered in Boston, Massachusetts, and has been active in building its pipeline and clinical capabilities since its formation.
1-888-653-2347 
support@leadiq.com 
